HealthTech provides management consulting services focused on community hospital management, including interim executive staffing, hospital management, technology, supply chain and consulting. The services are aimed at improving performance and sustainability in healthcare.

HealthTech

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.

Samuel Levy

Shantanu Gaur

Allurion Technologies Inc.

Biofourmis harnesses the power of technology and data to shape innovations that bring the right care to every person, no matter where they are. The company aims to make care simpler, science smarter, and patients healthier.

Xuejiao Zhao

Kuldeep Rajput

Maulik Majmudar

Biofourmis

Castle Creek Biosciences develops novel gene therapies to improve lives. The company focuses on cell and gene therapy for patients and families.

Metric
Company Name	HealthTech	Allurion Technologies Inc.	Biofourmis	Castle Creek Biosciences
Symbol		ALUR
MSH ID	US:HEALTH-TECH	COM:ALLURION	COM:BIOFOURMIS	COM:CASTLECREEKBIO
Market	PRIVATE	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare	Healthcare & Health Services	Healthcare & Health Services
Industry	Healthcare Consulting	Medical - Devices	Healthcare Technology	Biotechnology
Country	US	US	US	US
Stage				Venture Round
Employee Count		501	451
Website	health-tech.us	allurion.com	biofourmis.com	castlecreekbio.com
LinkedIn		allurion-technologies	biofourmis	castlecreekbio
Founders

Metric
Market Cap		64.25M
Enterprise Value
Monthly Web Traffic	706		261
Web Traffic Growth	14.35		-0.89
Valuation
Raised Capital			112.80M

Metric
Revenue		53.47M
Revenue (LTM)
Revenue (NTM)
Gross Profit		41.50M
EBITDA		-79.08M
Operating Income		-79.08M
Net Income		-80.61M
EPS		-2.27
Diluted EPS		-2.27
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.78
Operating Profit Margin		-0.99
EBITDA Margin		-1.48
Net Profit Margin		-0.79
Return on Equity		1.00
Return on Assets		-0.61
Return on Capital Employed		12.27

HEAL

US:HEALTH-TECH

HealthTech

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		-1.50
P/B Ratio		-2.10
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		2.10
EV Multiple		-0.17

Metric
Days Sales Outstanding		156.64
Days Payables Outstanding		242.28
Days Inventory Outstanding		186.61
Operating Cycle		310.82
Cash Conversion Cycle		18.37
Asset Turnover		1.02

Metric
Operating Cash Flow		-63.98M
Free Cash Flow		-65.59M
Cash Flow to Debt		-0.96
Operating Cash Flow/Sales		-0.91
Free Cash Flow Yield		-0.46

Metric
Cash & Equivalents		38.04M
Accounts Receivable		-1.32M
Inventory		6.17M
Goodwill
Debt to Capitalization		7.35
Debt to Assets		0.51
Current Ratio		1.30
Quick Ratio		1.51

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.10
R&D to Revenue		0.42
SG&A to Revenue		0.55